Related Experiment Video
Updated: Feb 7, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Two novel TSC2 mutations in pediatric patients with tuberous sclerosis complex: Case report
Shan Gao1, Zhiling Wang, Yongmei Xie
1Department of Pediatric Neurology and Gastroenterology, West China Second University Hospital Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, Sichuan University, Chengdu, P.R. China.
This study identifies two novel mutations in the TSC2 gene, a frameshift and a missense mutation, in patients with tuberous sclerosis complex (TSC). Further research is needed to confirm their pathogenicity in TSC.
Area of Science:
- Genetics
- Molecular Biology
- Rare Diseases
Background:
- Tuberous sclerosis complex (TSC) is a rare autosomal dominant disorder.
- Mutations in the TSC1 and TSC2 genes are known causes of TSC.
- This study focuses on novel genetic variations within the TSC2 gene.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

